These 10 Stocks Are Making Big Moves

6. Moderna, Inc. (NASDAQ:MRNA)

Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed against Health Secretary Robert F. Kennedy Jr. over policies on COVID-19 vaccines.

On Monday, six medical organizations sued Kennedy and the Department of Health and Human Services over the agency’s decision to limit vaccine access. The plaintiffs sought to restore the COVID-19 vaccine to the list of recommended immunizations for healthy children and pregnant women.

The plaintiffs include the American Public Health Association, the American Academy of Pediatrics, the Infectious Diseases Society of America, the American College of Physicians, the Society for Maternal-Fetal Medicine and the Massachusetts Public Health Alliance.

“The secretary’s intentions are clear. He (Kennedy) aims to destroy vaccines,” said Richard Hughes IV, a lawyer who teaches vaccine law at George Washington University, who is leading the effort.

The lawsuit was viewed as a tailwind for Moderna, Inc. (NASDAQ:MRNA), one of the few pharmaceutical companies that successfully developed its own COVID-19 vaccine during the pandemic.